Aker BioMarine Plans US NDI Notification For EPA/DHA Formulated To Pass Blood-Brain Barrier

 
• By Eileen Francis
  
Aker BioMarine's Lysoveta EPA/DHA formulation is bound by lysophosphatidylcholine to allow the fatty acids to pass through the blood-brain barrier via transporter Mfsd2a.

More from Regulation

More from Policy & Regulation